StemSight
PrivateLast Round
Seed
Feb 11, 2025
Total Funding Raised
$1.89M
Company Overview
StemSight is a biotechnology company developing off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs) to treat corneal blindness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemSight Comparables
Compare StemSight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellusion Inc. | 77% | |
| Alcon | 74% | |
| Chiesi Farmaceutici S.p.A. | 73% | |
StemSight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 11, 2025 | ||||
| Pre Seed | Aug 31, 2021 |
Key People
Founding team and executive leadership
StemSight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Seed |
| Biothom Oy | Seed |
| European Regional Development Fund (ERDF) | Grant |
| Voima Ventures | Pre Seed, Seed |
| Avohoidon Tutkimussäätiö | Pre Seed |
| Stephen Industries Inc Oy | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 891% MoM.
- Jan 6, 2026
Monthly visitors grew 258% MoM, reaching 974.
StemSight Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about StemSight's valuation, stock price, and market status.